Skip to content

clinical and histopathological study of drug reactions in skin

Clinicopathological study of adverse cutaneous drug reactions

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/03/023893
Enrollment
34
Registered
2020-03-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L989- Disorder of the skin and subcutaneous tissue, unspecified

Interventions

None listed

Sponsors

Dr Amulya s
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A clinical and histological study of patients who present to the father muller hospital opd or in admission who are clinically diagnosed as adverse cutaneous drug reactions.

Exclusion criteria

Exclusion criteria: 1) age below 12 years 2) patients who refuse to be included in the study 3) patients who are not clinically diagnosed as adverse cutaneous drug reaction

Design outcomes

Primary

MeasureTime frame
1) To assess the various clinical and pathological presentation of cutaneous adverse drug reactions 2) To assess the commonly involved drugs in adverse cutaneous drug reactions 3) To correlate the clinical and histopathological findings of cutaneous adverse drug reactions. Timepoint: 2 years

Secondary

MeasureTime frame
2) To assess the commonly involved drugs in adverse cutaneous drug reactions Timepoint: to assess after the study

Countries

India

Contacts

Public ContactDr Amulya S

Father Muller Medical College and Hospital

dr_martisj@yahoo.co.in9845148112

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026